{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T15:23:10Z","timestamp":1789226590281,"version":"build-2803163510"},"reference-count":38,"publisher":"Japanese Circulation Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2021,9,24]]},"DOI":"10.1253\/circj.cj-21-0098","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T18:06:31Z","timestamp":1624471591000},"page":"1756-1767","source":"Crossref","is-referenced-by-count":50,"title":["One-Year Outcome After Percutaneous Coronary Intervention for Acute Coronary Syndrome\u3000\u2015 An Analysis of 20,042 Patients From a Japanese Nationwide Registry \u2015"],"prefix":"10.1253","volume":"85","author":[{"given":"Mitsuaki","family":"Sawano","sequence":"first","affiliation":[{"name":"Department of Cardiology, Keio University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Kohsaka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Keio University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fujita Health University Bantane Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Numasawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Japanese Red Cross Ashikaga Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyohei","family":"Yamaji","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kokura Memorial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Inohara","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Keio University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Amano","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Aichi-Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Ikari","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tokai University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Toho University Ohashi Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. The Lancet. 40 years of percutaneous coronary intervention: Where next? <i>Lancet<\/i> 2017; 390: 715.","DOI":"10.1016\/S0140-6736(17)32238-9"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al. Heart disease and stroke statistics-2018 update: A report from the American Heart Association. <i>Circulation<\/i> 2018; 137: e67\u2013e492.","DOI":"10.1161\/CIR.0000000000000573"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ozaki Y, Katagiri Y, Onuma Y, Amano T, Muramatsu T, Kozuma K, et al. CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) in 2018. <i>Cardiovasc Interv Ther<\/i> 2018; 33: 178\u2013203.","DOI":"10.1007\/s12928-018-0516-y"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Berg DD, Wiviott SD, Braunwald E, Guo J, Im K, Kashani A, et al. Modes and timing of death in 66 252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trials. <i>Eur Heart J<\/i> 2018; 39: 3810\u20133820.","DOI":"10.1093\/eurheartj\/ehy556"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Pilgrim T, Vranckx P, Valgimigli M, Stefanini GG, Piccolo R, Rat J, et al. Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction. <i>Am Heart J<\/i> 2016; 175: 56\u201365.","DOI":"10.1016\/j.ahj.2016.01.021"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Alkhouli M, Alqahtani F, Kalra A, Gafoor S, Alhajji M, Alreshidan M, et al. Trends in characteristics and outcomes of patients undergoing coronary revascularization in the United States, 2003\u20132016. <i>JAMA Netw Open<\/i> 2020; 3: e1921326.","DOI":"10.1001\/jamanetworkopen.2019.21326"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Fokkema ML, James SK, Albertsson P, Akerblom A, Calais F, Eriksson P, et al. Population trends in percutaneous coronary intervention: 20-year results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry). <i>J Am Coll Cardiol<\/i> 2013; 61: 1222\u20131230.","DOI":"10.1016\/j.jacc.2013.01.007"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Hira RS, Bhatt DL, Fonarow GC, Heidenreich PA, Ju C, Virani SS, et al. Temporal trends in care and outcomes of patients receiving fibrinolytic therapy compared to primary percutaneous coronary intervention: Insights from the Get With The Guidelines Coronary Artery Disease (GWTG-CAD) Registry. <i>J Am Heart Assoc<\/i> 2016; 5: e004113.","DOI":"10.1016\/S0735-1097(15)60068-7"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Inoue T, Kuwabara H, Fushimi K. Regional variation in the use of percutaneous coronary intervention in Japan. <i>Circ J<\/i> 2017; 81: 195\u2013198.","DOI":"10.1253\/circj.CJ-16-0772"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Sawano M, Yamaji K, Kohsaka S, Inohara T, Numasawa Y, Ando H, et al. Contemporary use and trends in percutaneous coronary intervention in Japan: An outline of the J-PCI registry. <i>Cardiovasc Interv Ther<\/i> 2020; 35: 218\u2013226.","DOI":"10.1007\/s12928-020-00669-z"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Yamaji K, Kohsaka S, Morimoto T, Fujii K, Amano T, Uemura S, et al. Relation of ST-segment elevation myocardial infarction to daily ambient temperature and air pollutant levels in a Japanese Nationwide Percutaneous Coronary Intervention Registry. <i>Am J Cardiol<\/i> 2017; 119: 872\u2013880.","DOI":"10.1016\/j.amjcard.2016.11.041"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Inohara T, Kohsaka S, Yamaji K, Amano T, Fujii K, Oda H, et al. Impact of institutional and operator volume on short-term outcomes of percutaneous coronary intervention: A report from the Japanese Nationwide Registry. <i>JACC Cardiovasc Interv<\/i> 2017; 10: 918\u2013927.","DOI":"10.1016\/S0735-1097(17)34755-1"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Numasawa Y, Inohara T, Ishii H, Yamaji K, Kohsaka S, Sawano M, et al. Comparison of outcomes after percutaneous coronary intervention in elderly patients, including 10 628 nonagenarians: Insights from a Japanese Nationwide Registry (J-PCI Registry). <i>J Am Heart Assoc<\/i> 2019; 8: e011183.","DOI":"10.1161\/JAHA.118.011017"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Murakami A, Hirata Y, Motomura N, Miyata H, Iwanaka T, Takamoto S. The National Clinical Database as an initiative for quality improvement in Japan. <i>Korean J Thorac Cardiovasc Surg<\/i> 2014; 47: 437\u2013443.","DOI":"10.5090\/kjtcs.2014.47.5.437"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Inohara T, Kohsaka S, Yamaji K, Amano T, Fujii K, Oda H, et al. Impact of institutional and operator volume on short-term outcomes of percutaneous coronary intervention: A report from the Japanese Nationwide Registry. <i>JACC Cardiovasc Interv<\/i> 2017; 10: 918\u2013927.","DOI":"10.1016\/S0735-1097(17)34755-1"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Hicks KA, Mahaffey KW, Mehran R, Nissen SE, Wiviott SD, Dunn B, et al. 2017 Cardiovascular and stroke endpoint definitions for clinical trials. <i>Circulation<\/i> 2018; 137: 961\u2013972.","DOI":"10.1161\/CIRCULATIONAHA.117.033502"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Garcia-Garcia HM, McFadden EP, Farb A, Mehran R, Stone GW, Spertus J, et al. Standardized end point definitions for coronary intervention trials: The Academic Research Consortium-2 Consensus Document. <i>Circulation<\/i> 2018; 137: 2635\u20132650.","DOI":"10.1161\/CIRCULATIONAHA.117.029289"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Robins JM, Hernan MA, Brumback B. Marginal structural models and causal inference in epidemiology. <i>Epidemiology<\/i> 2000; 11: 550\u2013560.","DOI":"10.1097\/00001648-200009000-00011"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Inohara T, Kohsaka S, Yamaji K, Ishii H, Amano T, Uemura S, et al. Risk stratification model for in-hospital death in patients undergoing percutaneous coronary intervention: A nationwide retrospective cohort study in Japan. <i>BMJ Open<\/i> 2019; 9: e026683.","DOI":"10.1136\/bmjopen-2018-026683"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kinjo K, Sato H, Sato H, Ohnishi Y, Hishida E, Nakatani D, et al. Prognostic significance of atrial fibrillation\/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention. <i>Am J Cardiol<\/i> 2003; 92: 1150\u20131154.","DOI":"10.1016\/j.amjcard.2003.07.021"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kasanuki H, Honda T, Haze K, Sumiyoshi T, Horie T, Yagi M, et al. A large-scale prospective cohort study on the current status of therapeutic modalities for acute myocardial infarction in Japan: Rationale and initial results of the HIJAMI Registry. <i>Am Heart J<\/i> 2005; 150: 411\u2013418.","DOI":"10.1016\/j.ahj.2004.10.001"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Daida H, Miyauchi K, Ogawa H, Yokoi H, Matsumoto M, Kitakaze M, et al. Management and two-year long-term clinical outcome of acute coronary syndrome in Japan: Prevention of atherothrombotic incidents following ischemic coronary attack (PACIFIC) registry. <i>Circ J<\/i> 2013; 77: 934\u2013943.","DOI":"10.1253\/circj.CJ-13-0174"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Jernberg T, Attebring MF, Hambraeus K, Ivert T, James S, Jeppsson A, et al. The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART). <i>Heart<\/i> 2010; 96: 1617\u20131621.","DOI":"10.1136\/hrt.2010.198804"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Fanaroff AC, Zakroysky P, Wojdyla D, Kaltenbach LA, Sherwood MW, Roe MT, et al. Relationship between operator volume and long-term outcomes after percutaneous coronary intervention. <i>Circulation<\/i> 2019; 139: 458\u2013472.","DOI":"10.1161\/CIRCULATIONAHA.117.033325"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Spoon DB, Psaltis PJ, Singh M, Holmes DRJ, Gersh BJ, Rihal CS, et al. Trends in cause of death after percutaneous coronary intervention. <i>Circulation<\/i> 2014; 129: 1286\u20131294.","DOI":"10.1161\/CIRCULATIONAHA.113.006518"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Brener SJ, Tarantini G, Leon MB, Serruys PW, Smits PC, von Birgelen C, et al. Cardiovascular and noncardiovascular death after percutaneous coronary intervention: Insights from 32 882 patients enrolled in 21 randomized trials. <i>Circ Cardiovasc Interv<\/i> 2018; 11: e006488.","DOI":"10.1161\/CIRCINTERVENTIONS.118.006488"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Russo AM, Stainback RF, Bailey SR, Epstein AE, Heidenreich PA, Jessup M, et al. ACCF\/HRS\/AHA\/ASE\/HFSA\/SCAI\/SCCT\/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: A report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. <i>J Am Coll Cardiol<\/i> 2013; 61: 1318\u20131368.","DOI":"10.1016\/j.jacc.2012.12.017"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. <i>N Engl J Med<\/i> 2004; 351: 2481\u20132488.","DOI":"10.1056\/NEJMoa041489"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Steinbeck G, Andresen D, Seidl K, Brachmann J, Hoffmann E, Wojciechowski D, et al. Defibrillator implantation early after myocardial infarction. <i>N Engl J Med<\/i> 2009; 361: 1427\u20131436.","DOI":"10.1056\/NEJMoa0901889"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Kimura K, Kimura T, Ishihara M, Nakagawa Y, Nakao K, Miyauchi K, et al. JCS 2018 guideline on diagnosis and treatment of acute coronary syndrome. <i>Circ J<\/i> 2019; 83: 1085\u20131196.","DOI":"10.1253\/circj.CJ-19-0133"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. <i>Lancet<\/i> 2004; 364: 937\u2013952.","DOI":"10.1016\/S0140-6736(04)17018-9"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Pouche M, Ruidavets JB, Ferri\u00e8res J, Iliou MC, Douard H, Lorgis L, et al. Cardiac rehabilitation and 5-year mortality after acute coronary syndromes: The 2005 French FAST-MI study. <i>Arch Cardiovasc Dis<\/i> 2016; 109: 178\u2013187.","DOI":"10.1016\/j.acvd.2015.09.009"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Olgin JE, Pletcher MJ, Vittinghoff E, Wranicz J, Malik R, Morin DP, et al. Wearable cardioverter-defibrillator after myocardial infarction. <i>N Engl J Med<\/i> 2018; 379: 1205\u20131215.","DOI":"10.1056\/NEJMoa1800781"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Kuramitsu S, Ohya M, Shinozaki T, Otake H, Horie K, Kawamoto H, et al. Risk factors and long-term clinical outcomes of second-generation drug-eluting stent thrombosis. <i>Circ Cardiovasc Interv<\/i> 2019; 12: e007822.","DOI":"10.1161\/CIRCINTERVENTIONS.119.007822"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Costa F, van Klaveren D, James S, Heg D, Raber L, Feres F, et al. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: A pooled analysis of individual-patient datasets from clinical trials. <i>Lancet<\/i> 2017; 389: 1025\u20131034.","DOI":"10.1016\/S0140-6736(17)30397-5"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Rafique AM, Nayyar P, Wang TY, Mehran R, Baber U, Berger PB, et al. Optimal P2Y<sub>12<\/sub> inhibitor in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A network meta-analysis. <i>JACC Cardiovasc Interv<\/i> 2016; 9: 1036\u20131046.","DOI":"10.1016\/j.jcin.2016.02.013"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Kandzari DE, Mauri L, Koolen JJ, Massaro JM, Doros G, Garcia-Garcia HM, et al. Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): A randomised trial. <i>Lancet<\/i> 2017; 390: 1843\u20131852.","DOI":"10.1016\/S0140-6736(17)32249-3"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Sawano M, Kohsaka S, Abe T, Inohara T, Maekawa Y, Ueda I, et al. Patterns of statin non-prescription in patients with established coronary artery disease: A report from a contemporary multicenter Japanese PCI registry. <i>PLoS One<\/i> 2017; 12: e0182687.","DOI":"10.1371\/journal.pone.0182687"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/85\/10\/85_CJ-21-0098\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T23:58:29Z","timestamp":1632527909000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/85\/10\/85_CJ-21-0098\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,24]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-21-0098","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,24]]},"article-number":"CJ-21-0098"}}